Frontlight ResearchEarly access
Trial site
Sarah Cannon Research Institute
- 1running trial
- 2closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer1 trial
- Metastatic breast cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 22 trials
- Phase 1/21 trial
- Status
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Astellas Pharma Global Development, Inc.1 trial
- Dana-Farber Cancer Institute1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026